Literature DB >> 5018658

Treatment and prevention of pulmonary complications of cystic fibrosis in infancy and early childhood.

M B Mearns.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 5018658      PMCID: PMC1648003          DOI: 10.1136/adc.47.251.5

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


× No keyword cloud information.
  5 in total

1.  Pulmonary changes in cystic fibrosis of the pancreas. A radio-pathological study.

Authors:  C J HODSON; N E FRANCE
Journal:  Clin Radiol       Date:  1962-01       Impact factor: 2.350

2.  Cystic fibrosis: nature and prognosis.

Authors:  W J Warwick
Journal:  Minn Med       Date:  1967-07

3.  Bacterial precipitins in serum of patients with cystic fibrosis.

Authors:  M W Burns; J R May
Journal:  Lancet       Date:  1968-02-10       Impact factor: 79.321

4.  Studies in cystic fibrosis. Report of 130 patients diagnosed under 3 months of age over a 20-year period.

Authors:  H Shwachman; A Redmond; K T Khaw
Journal:  Pediatrics       Date:  1970-09       Impact factor: 7.124

5.  Mist tent therapy of the obstructive pulmonary lesion of cystic fibrosis.

Authors:  L W Matthews; C F Doershuk; S Spector
Journal:  Pediatrics       Date:  1967-02       Impact factor: 7.124

  5 in total
  11 in total

1.  Trial of artificial diet in treatment of cystic fibrosis of pancreas.

Authors:  R P Barclay; R S Shannon
Journal:  Arch Dis Child       Date:  1975-06       Impact factor: 3.791

2.  The periodic health examination. Canadian Task Force on the Periodic Health Examination.

Authors: 
Journal:  Can Med Assoc J       Date:  1979-11-03       Impact factor: 8.262

3.  Problems affecting the community. Population screening.

Authors:  B E Clayton
Journal:  J Clin Pathol Suppl (R Coll Pathol)       Date:  1974

4.  Mist therapy in cystic fibrosis.

Authors:  D Lawson
Journal:  Arch Dis Child       Date:  1973-05       Impact factor: 3.791

5.  Cystic fibrosis care-further considerations.

Authors:  C F Doershuck; L W Matthews; R C Stern; T F Boat
Journal:  Arch Dis Child       Date:  1972-12       Impact factor: 3.791

6.  Cystic fibrosis--assessing the effects of treatment.

Authors:  D Lawson
Journal:  Arch Dis Child       Date:  1972-02       Impact factor: 3.791

Review 7.  An overview of the management of cystic fibrosis.

Authors:  J M Littlewood
Journal:  J R Soc Med       Date:  1986       Impact factor: 5.344

8.  Cystic fibrosis in adults: the unsuspected pulmonary diagnosis.

Authors:  A J Nolan
Journal:  Can Med Assoc J       Date:  1976-01-24       Impact factor: 8.262

9.  Gentamicin and tobramycin compared in the treatment of mucoid pseudomonas lung infections in cystic fibrosis.

Authors:  A J Martin; C A Smalley; R H George; D E Healing; C M Anderson
Journal:  Arch Dis Child       Date:  1980-08       Impact factor: 3.791

10.  Efficacy of aerosol MP-376, a levofloxacin inhalation solution, in models of mouse lung infection due to Pseudomonas aeruginosa.

Authors:  Mojgan Sabet; Courtney E Miller; Thomas G Nolan; Kathy Senekeo-Effenberger; Michael N Dudley; David C Griffith
Journal:  Antimicrob Agents Chemother       Date:  2009-06-15       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.